One of India’s major pharma companies, Divi’s Laboratories share price witnessed a decline of close to 4 per cent soon after SBI Mutual Fund offloaded its stakes, as per an exchange filing on February 20, 2025.
SBI Mutual Fund had announced that it sold 1,40,560 shares, indicating a 0.0529 per cent of the paid-up share capital of the company on February 19, under the myriads of the scheme, the filing added.
Divi’s Laboratories Share Price History
Divi’s Laboratories declined by a 3.7 per cent intraday low on February 21, at 11:03 am, on BSE, slipping from the closing price of Rs 5976.4 on February 20 to Rs 5754.85 on February 21.
Advertisement
Despite the fall in share price, Divi's Labs has moved up to 56 paper cents in a year period, making its market capitalisation reach Rs 1.53 lakh crore.
Divi's Labs' 52-week high stood at Rs 6,285.45 apiece, on December 3, 2024, while it hit a 52-week low of Rs 3,350 on March 27, 2024, as per NSE.
Against this development, Divi's Labs' stock price opened marginally lower at Rs 5,960. After the announcement, the final stakeholding of SBI Mutual Fund under the several schemes stood at 1,33,99,732 shares, bringing down the overall shareholding to 5.0476 per cent of the paid-up stock capital of Divi’s Labs. Before the offloading announcement, SBI mutual Fund held about 1,35,40,292 or 5.1005 per cent stocks in the blue-chip pharma company.
Advertisement
Till February 2023, the stake ownership of India’s biggest mutual fund in Divi’s lab has gone down by 200 basis points from 7.0869 per cent to 5.0476 per cent.
In addition to SBI Mutual Fund, many known investors including Life Insurance Corporation Of India (LIC) and The Government Of Singapore also held stakes in the Pharma major. While LIC’s stakeholding in the blue-chip company stood at 6 per cent by the end of the December 2024 quarter, the Government Of Singapore’s stockholding was 2.4 per cent.
Advertisement
Nifty Pharma In The Red
Meanwhile, Nifty Pharma was down by 2.13 per cent or 443.40 points at 20,342.35.
Additionally, US President Donald Trump on February 18, hinted on a 25 per cent tariff on around 25 per cent tariffs to be imposed on pharmaceutical, automobile, and semiconductor imports. The announcement is possibly set for April 2.
When enquired about tariffs on pharmaceutical drugs and semiconductor chips, Trump said, “It’ll be 25 per cent and higher, and it’ll go very substantially higher over the course of a year.”
